Inozyme Pharma Stock Price History
| INZY Stock | USD 0.97 0.05 4.90% |
Below is the normalized historical share price chart for Inozyme Pharma extending back to July 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inozyme Pharma stands at 0.97, as last reported on the 19th of March, with the highest price reaching 1.04 and the lowest price hitting 0.92 during the day.
If you're considering investing in Inozyme Stock, it is important to understand the factors that can impact its price. Inozyme Pharma holds Efficiency (Sharpe) Ratio of -0.26, which attests that the entity had a -0.26 % return per unit of risk over the last 3 months. Inozyme Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inozyme Pharma's Market Risk Adjusted Performance of (0.81), standard deviation of 6.04, and Risk Adjusted Performance of (0.18) to validate the risk estimate we provide.
At this time, Inozyme Pharma's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 133.2 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 36.1 M in 2025. . At this time, Inozyme Pharma's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 3.16 in 2025, whereas Price Earnings Ratio is likely to drop (1.79) in 2025. Inozyme Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2020 | 200 Day MA 3.7557 | 50 Day MA 1.4699 | Beta 1.314 |
Inozyme |
Sharpe Ratio = -0.2565
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INZY |
Estimated Market Risk
| 6.17 actual daily | 55 55% of assets are less volatile |
Expected Return
| -1.58 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inozyme Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inozyme Pharma by adding Inozyme Pharma to a well-diversified portfolio.
Inozyme Pharma Stock Price History Chart
There are several ways to analyze Inozyme Stock price data. The simplest method is using a basic Inozyme candlestick price chart, which shows Inozyme Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 3, 2025 | 3.07 |
| Lowest Price | March 18, 2025 | 0.97 |
Inozyme Pharma March 19, 2025 Stock Price Synopsis
Various analyses of Inozyme Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Inozyme Stock. It can be used to describe the percentage change in the price of Inozyme Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Inozyme Stock.| Inozyme Pharma Price Action Indicator | (0.04) | |
| Inozyme Pharma Accumulation Distribution | 53,250 | |
| Inozyme Pharma Price Rate Of Daily Change | 0.95 | |
| Inozyme Pharma Price Daily Balance Of Power | (0.42) |
Inozyme Pharma March 19, 2025 Stock Price Analysis
Inozyme Stock Price History Data
The price series of Inozyme Pharma for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 2.07 with a coefficient of variation of 42.18. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.82. The median price for the last 90 days is 1.4.| Open | High | Low | Close | Volume | ||
| 03/18/2025 | 1.01 | 1.04 | 0.92 | 0.97 | 461,501 | |
| 03/17/2025 | 1.02 | 1.04 | 0.99 | 1.02 | 702,132 | |
| 03/14/2025 | 1.02 | 1.03 | 0.98 | 1.00 | 657,011 | |
| 03/13/2025 | 1.08 | 1.09 | 0.98 | 1.00 | 620,378 | |
| 03/12/2025 | 1.06 | 1.10 | 1.04 | 1.08 | 643,119 | |
| 03/11/2025 | 1.07 | 1.09 | 0.98 | 1.06 | 749,892 | |
| 03/10/2025 | 1.14 | 1.15 | 1.04 | 1.06 | 543,522 | |
| 03/07/2025 | 1.25 | 1.29 | 1.13 | 1.15 | 416,314 | |
| 03/06/2025 | 1.17 | 1.25 | 1.16 | 1.23 | 573,908 | |
| 03/05/2025 | 1.10 | 1.20 | 1.10 | 1.19 | 464,401 | |
| 03/04/2025 | 1.07 | 1.17 | 1.04 | 1.12 | 493,531 | |
| 03/03/2025 | 1.23 | 1.27 | 1.09 | 1.09 | 456,662 | |
| 02/28/2025 | 1.19 | 1.22 | 1.16 | 1.20 | 491,556 | |
| 02/27/2025 | 1.22 | 1.28 | 1.19 | 1.20 | 426,894 | |
| 02/26/2025 | 1.17 | 1.25 | 1.17 | 1.21 | 583,034 | |
| 02/25/2025 | 1.24 | 1.27 | 1.19 | 1.19 | 618,360 | |
| 02/24/2025 | 1.25 | 1.30 | 1.21 | 1.24 | 871,616 | |
| 02/21/2025 | 1.30 | 1.31 | 1.25 | 1.25 | 705,241 | |
| 02/20/2025 | 1.31 | 1.32 | 1.26 | 1.27 | 663,693 | |
| 02/19/2025 | 1.32 | 1.35 | 1.31 | 1.31 | 521,269 | |
| 02/18/2025 | 1.39 | 1.42 | 1.31 | 1.32 | 583,893 | |
| 02/14/2025 | 1.37 | 1.43 | 1.33 | 1.37 | 427,320 | |
| 02/13/2025 | 1.38 | 1.38 | 1.27 | 1.35 | 549,075 | |
| 02/12/2025 | 1.28 | 1.37 | 1.24 | 1.35 | 526,421 | |
| 02/11/2025 | 1.40 | 1.42 | 1.27 | 1.29 | 715,682 | |
| 02/10/2025 | 1.45 | 1.49 | 1.37 | 1.40 | 698,149 | |
| 02/07/2025 | 1.50 | 1.52 | 1.44 | 1.45 | 405,185 | |
| 02/06/2025 | 1.54 | 1.56 | 1.47 | 1.50 | 338,605 | |
| 02/05/2025 | 1.36 | 1.53 | 1.36 | 1.52 | 837,902 | |
| 02/04/2025 | 1.39 | 1.45 | 1.36 | 1.36 | 381,017 | |
| 02/03/2025 | 1.40 | 1.43 | 1.35 | 1.38 | 787,259 | |
| 01/31/2025 | 1.49 | 1.62 | 1.42 | 1.44 | 934,901 | |
| 01/30/2025 | 1.42 | 1.56 | 1.42 | 1.46 | 787,192 | |
| 01/29/2025 | 1.54 | 1.57 | 1.40 | 1.42 | 919,005 | |
| 01/28/2025 | 1.39 | 1.54 | 1.35 | 1.52 | 1,061,591 | |
| 01/27/2025 | 1.41 | 1.44 | 1.34 | 1.36 | 792,112 | |
| 01/24/2025 | 1.32 | 1.49 | 1.32 | 1.41 | 911,952 | |
| 01/23/2025 | 1.29 | 1.32 | 1.24 | 1.32 | 1,070,098 | |
| 01/22/2025 | 1.36 | 1.39 | 1.29 | 1.30 | 987,314 | |
| 01/21/2025 | 1.37 | 1.44 | 1.33 | 1.35 | 1,395,730 | |
| 01/17/2025 | 1.38 | 1.41 | 1.34 | 1.36 | 1,359,589 | |
| 01/16/2025 | 1.41 | 1.45 | 1.32 | 1.36 | 1,293,911 | |
| 01/15/2025 | 1.55 | 1.55 | 1.38 | 1.38 | 1,153,070 | |
| 01/14/2025 | 1.71 | 1.77 | 1.45 | 1.51 | 1,538,175 | |
| 01/13/2025 | 2.04 | 2.08 | 1.61 | 1.72 | 1,518,875 | |
| 01/10/2025 | 2.71 | 2.74 | 1.97 | 2.00 | 2,238,733 | |
| 01/08/2025 | 2.79 | 2.84 | 2.64 | 2.80 | 379,678 | |
| 01/07/2025 | 2.93 | 3.05 | 2.74 | 2.82 | 580,113 | |
| 01/06/2025 | 3.09 | 3.09 | 2.87 | 2.89 | 487,488 | |
| 01/03/2025 | 2.85 | 3.18 | 2.82 | 3.07 | 699,676 | |
| 01/02/2025 | 2.81 | 2.96 | 2.79 | 2.85 | 525,718 | |
| 12/31/2024 | 2.86 | 2.86 | 2.68 | 2.77 | 364,077 | |
| 12/30/2024 | 2.89 | 2.90 | 2.78 | 2.82 | 273,767 | |
| 12/27/2024 | 3.09 | 3.09 | 2.86 | 2.92 | 418,491 | |
| 12/26/2024 | 2.89 | 3.08 | 2.86 | 3.05 | 292,509 | |
| 12/24/2024 | 3.00 | 3.00 | 2.86 | 2.93 | 292,587 | |
| 12/23/2024 | 3.01 | 3.04 | 2.83 | 3.01 | 361,889 | |
| 12/20/2024 | 2.77 | 3.03 | 2.75 | 2.99 | 932,240 | |
| 12/19/2024 | 2.79 | 2.86 | 2.65 | 2.81 | 381,329 | |
| 12/18/2024 | 2.95 | 2.99 | 2.68 | 2.76 | 587,912 | |
| 12/17/2024 | 3.00 | 3.06 | 2.84 | 2.94 | 531,617 |
About Inozyme Pharma Stock history
Inozyme Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inozyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inozyme Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inozyme Pharma stock prices may prove useful in developing a viable investing in Inozyme Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 62.8 M | 36.1 M | |
| Net Loss | -60.4 M | -63.4 M |
Inozyme Pharma Quarterly Net Working Capital |
|
Inozyme Pharma Stock Technical Analysis
Inozyme Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Inozyme Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Inozyme Pharma's price direction in advance. Along with the technical and fundamental analysis of Inozyme Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inozyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.82) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Inozyme Stock Analysis
When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.